Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis

Shuso Takeda, Koichiro Misawa, Ikuo Yamamoto and Kazuhito Watanabe
Drug Metabolism and Disposition September 2008, 36 (9) 1917-1921; DOI: https://doi.org/10.1124/dmd.108.020909
Shuso Takeda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koichiro Misawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ikuo Yamamoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuhito Watanabe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 36 no. 9 1917-1921
DOI 
https://doi.org/10.1124/dmd.108.020909
PubMed 
18556441

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 7, 2008
  • Accepted June 10, 2008
  • Published online August 20, 2008.

Article Versions

  • Earlier version (June 12, 2008 - 10:04).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Shuso Takeda,
  2. Koichiro Misawa,
  3. Ikuo Yamamoto and
  4. Kazuhito Watanabe
  1. Organization for Frontier Research in Preventive Pharmaceutical Sciences (S.T., K.W.) and Department of Hygienic Chemistry, Faculty of Pharmaceutical Sciences (K.M., K.W.), Hokuriku University, Kanazawa, Japan; and School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Nobeoka, Japan (I.Y.)
  1. Address correspondence to:
    Kazuhito Watanabe, Department of Hygienic Chemistry, Faculty of Pharmaceutical Sciences, Hokuriku University, Ho-3 Kanagawa-machi, Kanazawa 920-1181, Japan. E-mail: k-watanabe{at}hokuriku-u.ac.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20172012317
Sep 20172411634
Oct 20172212623
Nov 20172110726
Dec 20172310020
Jan 20181813222
Feb 20182914939
Mar 20181927128
Apr 20181716827
May 20181717947
Jun 201847121142
Jul 2018916035
Aug 20181013629
Sep 20186416535
Oct 20184927053
Nov 20182526560
Dec 20182786138
Jan 2019375627
Feb 2019570315
Mar 2019407619
Apr 2019323417
May 20193711720
Jun 2019418711
Jul 2019332326
Aug 2019353412
Oct 20193961427
Nov 2019358619
Dec 2019369413
Jan 2020433414
Feb 202028446
Mar 202031449
May 202036568
Jun 2020466410
Jul 202031437
Aug 202041264
Sep 2020529149
Oct 202032646
Nov 2020364310
Dec 20204181012
Jan 2021525514
Feb 2021463315
Mar 20214801112
Apr 2021563615
May 202153037
Jun 202142687
Jul 20214231412
Aug 202138845
Sep 202145973
Oct 202142754
Nov 202148265
Dec 202171346
Jan 202280132
Feb 202268969
Mar 2022103735
Apr 202262645
May 202246666
Jun 202247022
Jul 2022530411
Aug 202242968
Sep 202243474
Oct 202244882
Nov 2022326511
Dec 202222625
Jan 202327731
Feb 202328935
Mar 202317242

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 36 (9)
Drug Metabolism and Disposition
Vol. 36, Issue 9
1 Sep 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis

Shuso Takeda, Koichiro Misawa, Ikuo Yamamoto and Kazuhito Watanabe
Drug Metabolism and Disposition September 1, 2008, 36 (9) 1917-1921; DOI: https://doi.org/10.1124/dmd.108.020909

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Cannabidiolic Acid as a Selective Cyclooxygenase-2 Inhibitory Component in Cannabis

Shuso Takeda, Koichiro Misawa, Ikuo Yamamoto and Kazuhito Watanabe
Drug Metabolism and Disposition September 1, 2008, 36 (9) 1917-1921; DOI: https://doi.org/10.1124/dmd.108.020909
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Metabolic enzymes in nintedanib metabolism
  • Mechanism of AO Inactivation by Hydralazine
  • Warfarin PBPK modeling with target binding
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics